| Molecule | Cat. No. | Product Name | Art | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| ICAM-1 | HOTAvitag IC1-H82E8 | Biotinylated Human ICAM-1 / CD54 Protein, His,Avitag™ (MALS verified) |  Human | HEK293 |  | MALSSDS-PAGE | $360.00 25ug |   | |
| ICAM-1 | Human ICAM-1 / CD54 Protein, Fc Tag | Human | HEK293 |  | SDS-PAGE | $375.00 200ug | | ||
| ICAM-1 | Human ICAM-1 / CD54 Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 |  | MALSSDS-PAGE | $415.00 100ug | | ||
| ICAM-1 | Avitag IC1-M82E8 | Biotinylated Mouse ICAM-1 / CD54 Protein, His,Avitag™ (MALS verified) |  Mouse | HEK293 |  | MALSSDS-PAGE | $415.00 25ug | |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Cinainu | Phase 3 Clinical | Legacy Healthcare (Switzerland) Sa | Alopecia Areata | Details | |
| Gebasaxturev | V-937; CVA-21 | Phase 2 Clinical | Viralytics Ltd | Breast Neoplasms; Head and Neck Neoplasms; Melanoma; Neoplasm Metastasis; Prostatic Neoplasms; Urinary Bladder Neoplasms | Details |
| AIC-100 | AIC-100 | Phase 1 Clinical | Affyimmune Therapeutics Inc, National Cancer Institute | Oncocytic cell carcinoma of the thyroid; Thyroid Carcinoma, Anaplastic | Details |
| 68Ga-ICAM-1pep | Phase 1 Clinical | Beijing Cancer Hospital | Neoplasms | Details |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Frühestes Markenname | Frühestes Genehmigungsland | Früheste Indikation | Früheste Genehmigungsgesellschaft | Früheste Genehmigungsdatum | Indikationen | Klinische Studie |
|---|---|---|---|---|---|---|---|---|---|---|
| Tocopherol acetate | DSE-9912 | Approved | National Institute Of Diabetes And Digestive And Kidney Diseases | Ephynal, Aquasol E | Japan | Vitamin E Deficiency; Diabetic Retinopathy; Atherosclerosis; Intermittent Claudication; Venous Thromboembolism; Thrombosis | Eisai Co Ltd | 1951-09-01 | Atherosclerosis; Diabetic Retinopathy; Intermittent Claudication; Metabolic Dysfunction-Associated Steatotic Liver Disease; Thrombosis; Venous Thromboembolism; Vitamin E Deficiency | Details |
| Ascorbic Acid/Biotin/Cholecalciferol/Cyanocobalamin/Dexpanthenol/Folic acid/Niacinamide/Pyridoxine/Riboflavin/Thiamine/Tocopherol Acetate/Vitamin A/Vitamin K | Approved | Sandoz Canada Inc | Infuvite Pediatric | United States | Avitaminosis | Sandoz Canada Inc | 2001-02-21 | Avitaminosis | Details |
